MidDiagnosed 2026-07-29 19:58:27 KSTCCHEAI Stock Diagnostic ReportChemed forecasts 2026 EPS of $25-$25.75 as VITAS targets 5.75%-6.25% ADC growth[MISTRAL] Chemed Corporation has raised its expected EPS for 2026 and announced the ADC growth rate for its VITAS business, presenting a positive outlook.View Source Article ↗ AI CATALYST SCORE75 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤